The largest database of trusted experimental protocols

Ly cov1404

Manufactured by Shanghai Model Organisms
Sourced in China

LY-CoV1404 is a laboratory equipment designed for the detection and analysis of biological samples. It utilizes advanced sensing technologies to provide accurate and reliable data. The core function of LY-CoV1404 is to facilitate scientific research and investigation, allowing researchers to obtain valuable insights from their samples.

Automatically generated - may contain errors

2 protocols using ly cov1404

1

Evaluating mAb Pharmacokinetics in Transgenic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transgenic mice with human neonatal Fc receptor (hFcRn) overexpression (C57BL/6JSmoc-Fcgrtem2(hFCGRT)Smoc) (Vendor: Shanghai Model Organisms Center, China) were used to evaluate the pharmacokinetic profiles of mAbs XG005, XG005-CYLK, and LY-CoV1404 (bebtelovimab). Twenty-seven mice were randomly assigned into three groups and a single dose of mAbs (10 mg/kg) were administrated based on their body weights. The serums samples were collected on different time points, including -1-day pre-infusion and 2, 4, 8, 24, 48, 96, 168, 240, 336, 504, 672, 840 h post-infusion. Sample analysis was conducted utilizing validated ELISA methods. Sample concentration data was collected on the INFINITE 200 PRO plate reader and processed using INFINITE 200 PRO Software (2013) Tecan. Pharmacokinetic parameters were evaluated using a non-compartmental approach with Phoenix WinNonlin software (Version 8.0.0.3176, Pharsight, CA).
+ Open protocol
+ Expand
2

Pharmacokinetic Evaluation of mAbs in Transgenic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transgenic mice (C57BL/6JSmoc) with human neonatal Fc receptor (hFcRn) overexpression (Vendor: Shanghai Model Organisms Center, China) were used to evaluate the pharmacokinetic profiles of mAbs XG005, XG005-CYLK, and LY-CoV1404 (bebtelovimab). Twenty-seven mice were randomly assigned into three groups and a single dose of mAbs (10 mg/kg) were administrated based on their body weights. The serums samples were collected on different time points, including −1-day pre-infusion and 2, 4, 8, 24, 48, 96, 168, 240, 336, 504, 672, 840 hours post-infusion. Sample analysis was conducted utilizing validated ELISA methods. Sample concentration data was collected on the INFINITE 200 PRO plate reader and processed using INFINITE 200 PRO Software (2013) Tecan. Pharmacokinetic parameters were evaluated using a non-compartmental approach with Phoenix WinNonlin software (Version 8.0.0.3176, Pharsight, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!